Acutaas Chemicals Limited share price

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limite…Read more

Website NSE हिंदी में BSE

HealthcareSpecialty ChemicalsNifty 500 Nifty Smallcap 250NSE: ACUTAASISIN INE00FF01025

16 Oct 2026, 3:29 PM IST₹3,206.00▲ 73.50 (2.35%)

Market Cap₹ 26,248 Cr.
Current Price₹ 3,206.00
High / Low₹ 3,740 / 1,551
Stock P/E68.2
Book Value₹ 202
Dividend Yield0.08 %
ROCE27.7 %
ROE24.00 %
Face Value₹ 5.0

More figures (10)

EPS (TTM)₹ 47.00
Price / Book15.88
OPM33.5 %
Debt / Equity0.02
Sales growth (3Y)29.5 %
Profit growth (3Y)62.3 %
Promoter holding38.3 %
EV / EBITDA48.1
Beta0.02
All-time high₹ 3,740

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
ACUTAAS	-4.15%	-10.54%	+36.99%	+88.05%	+106.39%	+72.85%	+35.73%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Acutaas Chemicals Limited is in the Specialty Chemicals industry (Basic Materials), with a market value of ₹26,248 crore.
It trades at 68.2 times its last 12 months' earnings and 15.9 times book value.
Revenue grew 29.5% a year over the last 3 years, profit 62.3% a year.
Return on equity was 24.0% and return on capital employed 27.7% in the latest year.
Debt was 0.02 times shareholders' equity.
The share price is 14.3% below its 52-week high and up 106.4% over one year.
Promoters and insiders hold about 38.3%; institutions about 28.6%.

Pros

Company is almost debt-free (debt is 0.02 times equity).
Sales have grown 29.5% a year over the last 3 years.
Profit has grown 62.3% a year over the last 3 years.
Latest quarter (Jun 2026): sales up 59% and profit up 70% from a year ago.
Healthy return on equity of 15.6% on average over the last 3 years.

Cons

Promoter holding has fallen by 7.25 points over 3 years, to 32.66%.
Trades at 15.9 times its book value.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Acutaas Chemicals Limited

Employees: 1,007
Head office: Surat
NSE industry: Healthcare

Basic MaterialsHealthcareSpecialty Chemicals

Part ofNifty 500 Nifty Smallcap 250

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Acutaas Chemicals	3,206.00	68.2	26,248	0.08	75	70.40	330	59.08	27.7	24.0	15.88	33.5	0.02	38.31	1,339	29.5
2.	Asian Paints	2,331.90	46.9	2,23,546	1.17	1,559	39.60	10,542	17.94	24.4	21.2	10.47	15.8	0.18	52.90	35,584	1.1
3.	Solar Industries India	20,011.00	90.9	1,81,080	0.06	653	92.66	3,668	70.26	29.5	31.4	28.85	24.9	0.29	43.92	9,612	12.4
4.	Pidilite Industries	1,502.80	57.8	1,53,066	0.76	884	30.29	4,552	21.27	28.5	23.8	14.12	21.6	0.04	69.28	14,601	7.4
5.	Berger Paints India	473.95	45.4	55,263	0.85	405	28.56	3,584	11.97	20.6	17.2	7.99	12.6	0.09	75.60	11,880	4.2
6.	Linde India	6,184.50	96.5	52,744	0.07	105	-11.67	694	17.32	16.3	13.6	12.36	26.7	0.02	77.98	2,530	0.3
7.	Gujarat Fluorochemicals	4,402.90	79.1	48,366	0.07	219	19.02	1,588	23.97	9.6	7.6	6.32	17.1	0.29	66.44	4,875	-4.5
8.	Himadri Speciality Chemical	660.70	41.5	33,337	0.12	231	31.33	1,691	57.93	21.0	17.8	7.08	20.1	0.16	57.43	4,661	3.7
9.	Aether Industries	1,538.60	86.6	20,422	0.00	63	33.45	327	27.49	12.1	9.4	8.31	24.0	0.19	76.58	1,160	20.2
10.	Aarti Industries	503.00	34.4	18,246	0.20	155	61.46	2,387	22.47	7.5	7.3	3.05	8.7	0.83	42.15	8,162	7.9
	Median: 61 Co.	1,935.25	35.8	4,547	0.30	225	32.39	2,039	23.22	20.8	9.4	3.35	9.5	0.17	61.94	6,519	4.9

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	142	172	166	225	177	247	275	308	207	306	393	433	330
YOY Sales Growth %	8.66%	17.26%	9.25%	20.70%	24.11%	43.15%	65.21%	37.13%	17.30%	24.10%	42.98%	40.28%	59.08%
	117	148	140	182	147	198	206	224	156	211	243	249	217
Material Cost %	55%	59%	57%	60%	58%	57%	54%	53%	47%	44%	43%	38%	42%
Employee Cost %	10%	9%	10%	8%	11%	8%	8%	8%	12%	10%	8%	8%	12%
Other Expenses %	17%	17%	17%	13%	15%	16%	13%	12%	17%	15%	11%	12%	12%
Operating Profit	25	25	27	43	30	49	69	85	51	95	151	184	113
OPM %	18%	14%	16%	19%	17%	20%	25%	28%	25%	31%	38%	42%	34%
	1	2	3	1	1	8	2	6	16	10	5	11	2
Exceptional items		-32		-0
Interest	1	1	3	2	4	1	1	1	1	1	1	1	1
Depreciation	3	4	4	5	6	7	6	7	8	8	10	10	10
Profit before tax	22	-10	24	37	20	50	63	83	58	96	145	184	104
	25%		25%	31%	26%	25%	28%	24%	24%	25%	27%	27%	28%
Current tax	5	6	5	9	5	12	17	16	13	19	36	49	27
Deferred tax	0	1	1	3	1	0	1	5	1	5	2	1	2
	17	-17	18	26	15	38	45	63	44	72	106	134	75
Minority share		2	1	1	1	0	0	0	-0	-0	-2	3	1
Profit to shareholders		-19	17	25	14	37	45	62	44	72	108	132	74
YOY Profit Growth %	12.03%	-189.40%	-20.06%	-5.59%	-11.77%		155.13%	144.23%	199.60%	91.28%	133.73%	114.11%	70.40%
EPS in Rs	2.29	-2.34	2.42	3.43	1.84	4.69	5.68	7.80	5.41	8.82	13.19	16.09	9.07
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	142	164	162	220	171	244	271	304	206	305	391	422	322
YOY Sales Growth %	8.66%	11.30%	6.13%	18.00%	20.22%	48.90%	67.56%	38.29%	20.35%	25.29%	44.26%	38.67%	56.53%
	117	145	138	180	145	195	204	220	155	209	237	241	213
Material Cost %	55%	61%	59%	61%	59%	57%	54%	53%	47%	44%	43%	39%	43%
Employee Cost %	10%	9%	10%	7%	11%	8%	8%	7%	12%	9%	7%	7%	12%
Other Expenses %	17%	18%	17%	13%	15%	15%	13%	12%	16%	15%	11%	11%	11%
Operating Profit	25	19	24	40	26	48	67	84	51	97	154	181	110
OPM %	18%	11%	15%	18%	15%	20%	25%	28%	25%	32%	39%	43%	34%
	1	1	3	9	2	9	2	6	16	9	6	15	4
Exceptional items		-32
Interest	1	1	3	2	4	0	1	0	1	1	1	1	1
Depreciation	3	3	4	4	6	6	6	7	7	8	9	9	9
Profit before tax	23	-16	20	42	18	50	63	83	59	97	151	186	104
	25%		23%	24%	25%	25%	28%	24%	24%	25%	26%	26%	27%
Current tax	5	4	4	7	4	12	16	15	13	19	36	47	26
Deferred tax	0	1	1	3	1	0	1	5	2	5	3	2	3
	17	-21	16	32	14	38	45	63	45	73	112	137	76
YOY Profit Growth %	13.44%	-210.08%	-29.53%	18.12%	-18.65%		188.53%	95.91%	225.51%	93.46%	146.25%	118.10%	69.99%
EPS in Rs	2.32	-2.88	2.13	4.38	1.72	4.71	5.66	7.84	5.45	8.90	13.63	16.74	9.27
Raw filing

Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	520	617	717	1,007	1,339	1,462
YOY Sales Growth %		18.57%	16.33%	40.34%	33.02%
	415	494	589	775	859	919
Material Cost %	52%	54%	57%	55%	42%	42%
Employee Cost %	8%	8%	9%	8%	9%	9%
Other Expenses %	19%	19%	16%	14%	13%	12%
Operating Profit	105	123	128	232	480	543
OPM %	20%	20%	18%	23%	36%	37%
	3	4	7	17	42	27
Exceptional items			-32
Interest	6	2	6	6	3	4
Depreciation	10	12	16	27	36	38
Profit before tax	91	112	82	216	483	529
	21%	26%	41%	26%	26%	27%
Current tax	17	26	29	49	117
Deferred tax	3	3	4	7	9
	72	83	49	160	356	387
Minority share			6	2	0	1
Profit to shareholders			43	159	356	386
YOY Profit Growth %		15.77%	-41.52%	229.35%	122.15%
EPS in Rs	10.52	11.43	5.84	19.81	43.51	47.17
Dividend Payout %			26%	8%	3%

Compounded Sales Growth

3 Years:: 29%
TTM:: 41%

Compounded Profit Growth

3 Years:: 62%
TTM:: 104%

Stock Price CAGR

5 Years:: 36%
3 Years:: 73%
1 Year:: 106%

Return on Equity

4 Years:: 15%
Last Year:: 24%

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	520	617	688	990	1,324	1,440
YOY Sales Growth %		18.57%	11.49%	43.96%	33.74%
	415	494	580	765	841	899
Material Cost %	52%	54%	59%	55%	42%	42%
Employee Cost %	8%	8%	9%	8%	8%	9%
Other Expenses %	19%	19%	16%	14%	13%	12%
Operating Profit	105	123	108	225	483	542
OPM %	20%	20%	16%	23%	36%	38%
	3	4	14	18	46	34
Exceptional items			-32
Interest	6	2	6	6	3	4
Depreciation	10	12	15	24	33	35
Profit before tax	91	112	69	214	493	538
	21%	26%	37%	25%	26%	26%
Current tax	17	26	21	47	115
Deferred tax	3	3	5	7	11
	72	83	44	160	366	397
YOY Profit Growth %		15.84%	-47.58%	265.22%	129.51%
EPS in Rs	10.52	11.44	5.96	19.91	44.73	48.54
Dividend Payout %		13%	25%	8%	3%

Compounded Sales Growth

3 Years:: 29%
TTM:: 41%

Compounded Profit Growth

3 Years:: 64%
TTM:: 109%

Stock Price CAGR

5 Years:: 36%
3 Years:: 73%
1 Year:: 106%

Return on Equity

4 Years:: 15%
Last Year:: 24%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	36	37	41	41
Reserves	558	637	1,269	1,613
	4	217	13	36
Long term borrowings	1	114
Short term borrowings	3	103	8	26
	169	205	227	295
Trade payables	142	135	156	154
Minority interest		9	10	57
Current liabilities	163	285	202	231
Total Liabilities	767	1,096	1,549	1,984
	260	530	687	983
Gross block	299	585	766	1,095
Accumulated depreciation	39	55	79	113
Goodwill & intangibles	41	67	65	112
CWIP	38	170	182	349
	468	396	680	652
Inventories	119	157	180	231
Trade receivables	230	206	290	363
Cash & equivalents	31	30	185	216
Current assets	457	493	792	881
Total Assets	767	1,096	1,549	1,984

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	66	125	118	292
Profit for the year	83	43	159	356
Working capital changes	-36	18	-70	-93
Direct taxes paid	-24	-24	-47	-112
	-33	-365	-224	-266
Fixed assets purchased	-96	-315	-195	-328
Fixed assets sold		1
Investments purchased		-66	-40	-1
Investments sold	61	13		54
	-12	239	261	4
Proceeds from borrowings		130
Interest paid	-2	-6	-6	-1
Dividends paid	-11	-11	-12	-12
Net Cash Flow	20	-1	156	30
Free Cash Flow	-31	-190	-76	-36

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	14.0%	6.7%	16.0%	24.0%
ROCE	—	19.0%	10.8%	16.5%	27.7%
Operating margin	—	18.1%	15.8%	20.5%	33.5%
Net margin	—	13.6%	6.0%	15.9%	26.8%
Debt / equity	—	0.01	0.32	0.01	0.02
Current ratio	—	2.81	1.73	3.91	3.82
Debtor days	—	137	106	106	100
Inventory days	—	116	126	111	137
Days payable	—	139	108	96	91
Cash conversion cycle	—	114	124	121	146
Working capital days	—	175	107	215	179

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 32.66%
FIIs 22.62%
DIIs 19.40%
Government 0.01%
Public 25.31%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	39.91%	39.91%	35.98%	35.97%	35.96%	35.96%	32.66%	32.66%	32.66%	32.66%	32.66%	32.66%
	11.65%	8.97%	12.92%	13.87%	15.52%	16.48%	16.94%	16.85%	16.67%	19.48%	21.61%	22.62%
Foreign portfolio investors (Cat. I)	11.46%	8.84%	12.73%	13.44%	14.79%	15.63%	16.44%	15.77%	15.62%	18.36%	20.27%	20.58%
Foreign portfolio investors (Cat. II)	0.20%	0.14%	0.20%	0.43%	0.73%	0.85%	0.50%	1.07%	1.05%	1.12%	1.34%	2.03%
	7.58%	6.81%	14.81%	19.93%	20.24%	18.31%	22.38%	22.59%	21.70%	19.60%	19.56%	19.40%
Mutual funds	5.44%	3.92%	8.61%	13.07%	13.68%	13.02%	16.27%	15.81%	15.11%	13.86%	14.17%	14.44%
Insurance companies	0.11%	0.31%	3.22%	4.21%	4.00%	2.97%	4.68%	4.84%	4.15%	3.25%	3.61%	3.64%
Alternative investment funds	2.03%	2.57%	2.98%	2.65%	2.55%	2.32%	1.43%	1.94%	2.44%	2.49%	1.77%	1.32%
Government					0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
	40.86%	44.31%	36.29%	30.23%	28.27%	29.23%	28.01%	27.89%	28.96%	28.24%	26.16%	25.31%
Retail (up to ₹2 lakh)	14.89%	17.95%	15.81%	14.95%	13.82%	14.89%	14.31%	14.19%	15.02%	14.81%	13.44%	13.57%
HNIs (above ₹2 lakh)	12.24%	12.06%	10.25%	9.78%	9.74%	9.29%	8.96%	8.60%	8.51%	8.40%	8.28%	7.58%
NRIs	1.46%	1.71%	1.54%	1.65%	1.36%	1.50%	1.38%	1.45%	1.51%	1.48%	1.31%	1.23%
Bodies corporate	10.42%	10.49%	6.78%	1.99%	1.58%	1.74%	1.62%	1.61%	1.63%	1.50%	1.25%	1.28%
No. of Shareholders	83,344	95,784	90,987	93,394	95,756	1,14,060	1,19,890	1,08,664	1,10,363	1,12,939	1,25,569	1,47,026

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Acutaas Chemicals

Holder (above 1%)	Stake
Kotak Nifty Alpha 50 Index FundMutual fund	2.86%
Axis Max Life Insurance Limited A/C Nifty Momentum Quality 50 FundInsurance	2.04%
SBI Nifty Smallcap 250 Index FundMutual fund	1.83%
Motilal Oswal Nifty Smallcap 250 Index FundMutual fund	1.81%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 14.44% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 17 Sep 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

Acutaas Chemicals (ACUTAAS) Share/Stock Price Live, NSETechGraph · 9 Oct 2026

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Acutaas Chemicals Limited

What is the share price of Acutaas Chemicals Limited today?

Acutaas Chemicals Limited (ACUTAAS) last traded at ₹3,206.00 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Acutaas Chemicals Limited?

About ₹26,248 crore at the latest price.

What is the P/E ratio of Acutaas Chemicals Limited?

About 68.2 times its earnings over the last 12 months.

Is Acutaas Chemicals Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Acutaas Chemicals Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Acutaas Chemicals Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Acutaas Chemicals Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding Acutaas Chemicals

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Acutaas Chemicals Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next